APA (7th ed.) Citation

H, G., S, R., A, D., A, C., EM, C., A, D., . . . C, L. (2024). Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology, 8(1), 150. https://doi.org/10.1038/s41698-024-00641-7

Chicago Style (17th ed.) Citation

H, Gogas, et al. "Baseline Biomarkers of Efficacy and On-treatment Immune-profile Changes Associated with Bempegaldesleukin Plus Nivolumab." NPJ Precision Oncology 8, no. 1 (2024): 150. https://doi.org/10.1038/s41698-024-00641-7.

MLA (9th ed.) Citation

H, Gogas, et al. "Baseline Biomarkers of Efficacy and On-treatment Immune-profile Changes Associated with Bempegaldesleukin Plus Nivolumab." NPJ Precision Oncology, vol. 8, no. 1, 2024, p. 150, https://doi.org/10.1038/s41698-024-00641-7.